JP2022512686A5 - - Google Patents

Info

Publication number
JP2022512686A5
JP2022512686A5 JP2021520209A JP2021520209A JP2022512686A5 JP 2022512686 A5 JP2022512686 A5 JP 2022512686A5 JP 2021520209 A JP2021520209 A JP 2021520209A JP 2021520209 A JP2021520209 A JP 2021520209A JP 2022512686 A5 JP2022512686 A5 JP 2022512686A5
Authority
JP
Japan
Prior art keywords
protein
vaccine
raldh
vaccine according
pseudouridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021520209A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022512686A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/055543 external-priority patent/WO2020077045A1/en
Publication of JP2022512686A publication Critical patent/JP2022512686A/ja
Publication of JP2022512686A5 publication Critical patent/JP2022512686A5/ja
Pending legal-status Critical Current

Links

JP2021520209A 2018-10-10 2019-10-10 レチンアルデヒドデヒドロゲナーゼをコードする修飾ｒｎａの使用 Pending JP2022512686A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862743943P 2018-10-10 2018-10-10
US62/743,943 2018-10-10
PCT/US2019/055543 WO2020077045A1 (en) 2018-10-10 2019-10-10 Uses of modified rna encoding retinaldehyde dehydrogenase

Publications (2)

Publication Number Publication Date
JP2022512686A JP2022512686A (ja) 2022-02-07
JP2022512686A5 true JP2022512686A5 (OSRAM) 2022-10-11

Family

ID=70164700

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021520209A Pending JP2022512686A (ja) 2018-10-10 2019-10-10 レチンアルデヒドデヒドロゲナーゼをコードする修飾ｒｎａの使用

Country Status (6)

Country Link
US (2) US20210338709A1 (OSRAM)
EP (1) EP3863646A4 (OSRAM)
JP (1) JP2022512686A (OSRAM)
AU (1) AU2019356940A1 (OSRAM)
CA (1) CA3115522A1 (OSRAM)
WO (1) WO2020077045A1 (OSRAM)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4284832A1 (en) * 2021-01-29 2023-12-06 (INSERM) Institut National de la Santé et de la Recherche Médicale Chlamydia trachomatis antigenic polypeptides and uses thereof for vaccine purposes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006119083A2 (en) * 2005-04-29 2006-11-09 Cbr Institute For Biomedical Research, Inc. Treating gastrointestinal diseases with modulation of retonic acid
AU2012304313A1 (en) * 2011-09-08 2014-03-06 University Of Florida Research Foundation, Inc. Materials and methods for modulating immune responses
US20160051669A1 (en) * 2014-08-21 2016-02-25 Georgia Regents University Research Institute, Inc. Compositions and methods for selectively modulating tregs
US10238741B2 (en) * 2014-10-10 2019-03-26 The Trustees Of Columbia University In The City Of New York Nucleic acid constructs for presentation of CD4 and CD8 epitopes, cellular transfection and uses thereof
ES3011733T3 (en) * 2015-02-13 2025-04-08 Transgene Immunotherapeutic vaccine and antibody combination therapy
JP6534146B2 (ja) * 2015-06-10 2019-06-26 国立大学法人 東京大学 ワクチン用アジュバント、ワクチン、及び免疫誘導方法
WO2017191274A2 (en) * 2016-05-04 2017-11-09 Curevac Ag Rna encoding a therapeutic protein

Similar Documents

Publication Publication Date Title
US11965000B2 (en) Respiratory syncytial virus (RSV) vaccine
CN111315407B (zh) 一种广谱抗流感疫苗免疫原及其应用
JP2023533772A5 (OSRAM)
CN113666990B (zh) 一种诱导广谱抗冠状病毒的t细胞疫苗免疫原及其应用
BR112012008946A2 (pt) sequência polinucletídica isolada , molécula pollinucleotídica de rna, vetor ou plasmídeo , célula hospedeira , vírus a ser expresso , vacina , polipetídeo e composição de vacina
JP2016539946A5 (OSRAM)
JP2010227101A5 (OSRAM)
JP2017507918A (ja) Ｈｐｖおよび関連する疾病のための免疫増強治療ワクチン
JP2017515508A5 (OSRAM)
JP2010162023A5 (OSRAM)
JP2015501840A5 (OSRAM)
JP2021518129A5 (OSRAM)
EP3494989B1 (en) Composite antigenic sequences and vaccines
US9593143B2 (en) Method for purifying protein complexes
US12390518B2 (en) Immunogenic composition
WO2023023940A1 (zh) 一种诱导广谱抗冠状病毒的t细胞疫苗免疫原及其应用
Verma et al. Norovirus (NoV) specific protective immune responses induced by recombinant P dimer vaccine are enhanced by the mucosal adjuvant FlaB
Schulze et al. A prime-boost vaccination protocol optimizes immune responses against the nucleocapsid protein of the SARS coronavirus
CN102000330B (zh) 一种核酸疫苗佐剂及其构建方法
JP2014534262A5 (OSRAM)
Karkhanis et al. Mucosal vaccine vectors: replication-competent versus replication-deficient poxviruses
CN1338310A (zh) 一种猪瘟病毒表位疫苗及其制备方法
CN102038951B (zh) 基于mcp-1设计的核酸疫苗佐剂及其构建方法
CN110382518A (zh) 用于血清型a型口蹄疫病毒的嵌合疫苗
KR102285401B1 (ko) 암 및 피부 병변 치료